GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Clinical trial NCT01384383 · TERMINATED
Trial details
- NCT number
- NCT01384383
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.